IN2014CH01141A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CH01141A IN2014CH01141A IN1141CH2014A IN2014CH01141A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A IN 1141CH2014 A IN1141CH2014 A IN 1141CH2014A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A
- Authority
- IN
- India
- Prior art keywords
- glucitol
- anhydro
- ethoxyphenyl
- chloro
- phenyl
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- -1 4-ethoxyphenyl Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229960002920 sorbitol Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1141CH2014 IN2014CH01141A (fr) | 2014-03-06 | 2015-03-06 | |
| US15/303,577 US20170029398A1 (en) | 2014-03-06 | 2015-03-06 | Process for the preparation of (1s)-1,5-anhydro-1-c-{4-chloro-3-4[(4-ethoxyphenyl)methyl]phenyl]-glucitol and its solvate thereof |
| PCT/IN2015/000119 WO2015132803A2 (fr) | 2014-03-06 | 2015-03-06 | Procédé pour la préparation de (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-d-glucitol et de son solvate |
| EP15758707.2A EP3114115A4 (fr) | 2014-03-06 | 2015-03-06 | Procédé pour la préparation de (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-d-glucitol et de son solvate |
| US16/202,840 US20190144411A1 (en) | 2014-03-06 | 2018-11-28 | Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1141CH2014 IN2014CH01141A (fr) | 2014-03-06 | 2015-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CH01141A true IN2014CH01141A (fr) | 2015-09-11 |
Family
ID=54055961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1141CH2014 IN2014CH01141A (fr) | 2014-03-06 | 2015-03-06 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20170029398A1 (fr) |
| EP (1) | EP3114115A4 (fr) |
| IN (1) | IN2014CH01141A (fr) |
| WO (1) | WO2015132803A2 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106316803B (zh) * | 2015-06-19 | 2019-07-09 | 重庆博腾制药科技股份有限公司 | 一种sglt-2抑制剂中间体的合成方法 |
| ES2896101T3 (es) | 2015-09-15 | 2022-02-23 | Laurus Labs Ltd | Cocristales de inhibidores de SGLT2, procedimiento para su preparación y composiciones farmacéuticas de los mismos |
| US9845303B2 (en) | 2015-10-19 | 2017-12-19 | Cadila Healthcare Limited | Process for the preparation of dapagliflozin |
| US10913762B2 (en) | 2016-01-27 | 2021-02-09 | Msn Laboratories Private Limited | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof |
| WO2017221211A1 (fr) * | 2016-06-24 | 2017-12-28 | Biocon Limited | Procédé de préparation de dapagliflozine et de son solvate |
| CN107641139A (zh) * | 2016-07-22 | 2018-01-30 | 江苏豪森药业集团有限公司 | 达格列净中间体的晶型及其制备方法 |
| CN108610316B (zh) * | 2016-12-09 | 2021-11-05 | 江苏豪森药业集团有限公司 | 达格列净的制备方法 |
| WO2018142422A1 (fr) * | 2017-02-02 | 2018-08-09 | Indoco Remedies Limited | Procédé de préparation de dapagliflozine |
| CN107417515A (zh) * | 2017-03-30 | 2017-12-01 | 上海常丰生物医药科技有限公司 | 一种合成达格列净中间体的新方法 |
| CN109705075B (zh) * | 2018-12-13 | 2022-12-23 | 苏中药业集团股份有限公司 | 一种达格列净的纯化方法 |
| CN110396040B (zh) * | 2019-09-09 | 2020-12-15 | 东南大学 | 一种一锅法合成二芳基甲缩酮的方法 |
| EP4114365A1 (fr) | 2020-03-05 | 2023-01-11 | KRKA, d.d., Novo mesto | Composition pharmaceutique comprenant un inhibiteur du sglt2 |
| EP4161912A1 (fr) | 2020-06-05 | 2023-04-12 | KRKA, d.d., Novo mesto | Préparation de dapagliflozine amorphe très pure |
| CN111748004A (zh) * | 2020-06-30 | 2020-10-09 | 药璞(上海)医药科技有限公司 | 一种高纯度达格列净中间体的晶型及其制备方法 |
| CN112500267A (zh) | 2020-12-04 | 2021-03-16 | 江苏慧聚药业有限公司 | 4-溴-2-(4’-乙氧基-苄基)-1-氯苯的制备 |
| CN113880796A (zh) * | 2021-10-14 | 2022-01-04 | 山东诚创蓝海医药科技有限公司 | 一种达格列净的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| PH12000002657B1 (en) * | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| BR0317929A (pt) * | 2003-01-03 | 2006-04-11 | Bristol Myers Squibb Co | métodos de produzir inibidores de sglt2 de glicosìdeo de c-arila |
| US7919598B2 (en) | 2006-06-28 | 2011-04-05 | Bristol-Myers Squibb Company | Crystal structures of SGLT2 inhibitors and processes for preparing same |
| KR101604119B1 (ko) * | 2011-06-14 | 2016-03-16 | 주식회사 녹십자 | 신규한 c-아릴 안사 sglt2 억제제 |
| CN103889429B (zh) * | 2011-10-31 | 2016-10-19 | 台湾神隆股份有限公司 | Sglt2抑制剂的结晶和非结晶形式 |
| WO2015104658A2 (fr) * | 2014-01-08 | 2015-07-16 | Dr. Reddy’S Laboratories Limited | Dispersion solide amorphe de dapagliflozine et procédé pour la préparation de dapagliflozine amorphe |
-
2015
- 2015-03-06 EP EP15758707.2A patent/EP3114115A4/fr not_active Withdrawn
- 2015-03-06 IN IN1141CH2014 patent/IN2014CH01141A/en unknown
- 2015-03-06 WO PCT/IN2015/000119 patent/WO2015132803A2/fr not_active Ceased
- 2015-03-06 US US15/303,577 patent/US20170029398A1/en not_active Abandoned
-
2018
- 2018-11-28 US US16/202,840 patent/US20190144411A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3114115A4 (fr) | 2017-08-23 |
| US20170029398A1 (en) | 2017-02-02 |
| WO2015132803A2 (fr) | 2015-09-11 |
| WO2015132803A3 (fr) | 2016-01-14 |
| US20190144411A1 (en) | 2019-05-16 |
| EP3114115A2 (fr) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CH01141A (fr) | ||
| PH12017500408B1 (en) | Heteroaryl compounds as btk inhibitors and uses thereof | |
| LT3230278T (lt) | Nauji metilpiperidino junginiai, naudingi mikrosomalinės prostaglandino e2 sintazės-1 slopinimui | |
| EP3209653A4 (fr) | Procédé de préparation de (r,s)-nicotine | |
| IN2014CH00247A (fr) | ||
| EA201691649A1 (ru) | Способ получения противогрибковых соединений | |
| EP3137074A4 (fr) | Antagonistes du récepteur ep2 des prostaglandines, dérivés, compositions et utilisations associés | |
| EA201691648A1 (ru) | Способ получения противогрибковых соединений | |
| EP3102554A4 (fr) | Conversion de 2, 3-butanediol en butadiène | |
| IL250038A0 (en) | 4,5 - dehydroisoxazole derivatives used as nampt inhibitors | |
| CL2017000152A1 (es) | Derivados de isoindolinona | |
| EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| MX2016015464A (es) | Composicion farmaceutica oral de isotretinoina. | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| CL2017000151A1 (es) | Derivados de piridona | |
| HK1221645A1 (zh) | Vmat2的苯并喹啉抑制剂 | |
| IN2014MU01192A (fr) | ||
| MA40447A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| MX2016015465A (es) | Composicion farmaceutica oral de isotretinoina. | |
| IN2014MU00195A (fr) | ||
| IN2014CH00304A (fr) | ||
| EP3102540A4 (fr) | Compositions comprenant un nanocomposite de zno à lacunes artificielles (ve), procédés de fabrication et d'utilisation d'une composition | |
| IN2014MU00194A (fr) | ||
| EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона | |
| EP3116774A4 (fr) | Douille d'isolation thermique destinée aux premiers étages du piston |